General - Laatste dingen 1 Flashcards
ERU
a. GYS-1
b. TRPM1
c. RYR1
d. GBE1
b. TRPM1
timolol
a. B adrenerge receptor blocker
B. koolzuuranhydrase remmer
a. B adrenerge receptor blocker
dorzolamide
a. B adrenerge receptor blocker
B. koolzuuranhydrase remmer
B. koolzuuranhydrase remmer
Leptin in obese donkeys
a. higher
b. lower
a. higher
Type A lactic acidosis
a. hypoxia
b. abscence of hypoxemia
a. hypoxia
Leptin in old donkeys
a. higher
b. lower
a. higher
Type B lactic acidosis
a. hypoxia
b. abscence of hypoxemia
b. abscence of hypoxemia
Dobutamine
a. B1 agonist
b. B2 agonist
c. a1 agonist
d. a2 agonist
a. B1 agonist
Norepinephrine
a. B1 agonist
b. B2 agonist
c. a1 agonist
d. a2 agonist
c. a1 agonist
Epineephrine
a. a
b. b
c. a en b
c. a en b
Phenylefrine
a. a
b. b
c. a en b
a. a
Lower PCO2
a. left shift
b. right shift
a. left shift
Lower [H+]
a. left shift
b. right shift
a. left shift
Higher temp
a. left shift
b. right shift
b. right shift
Higher DPG
a. left shift
b. right shift
b. right shift
Lower [PO4,3-]
a. left shift
b. right shift
a. left shift
Lower pH
a. left shift
b. right shift
b. right shift
Higher pH
a. left shift
b. right shift
a. left shift
Hydrophobic / low surface tension
a. SP-B and SP-C
b. SP-A and SP-D
a. SP-B and SP-C
Hydrophilic / antimicrobial
a. SP-B and SP-C
b. SP-A and SP-D
b. SP-A and SP-D
Medial compartment
a. IX, XI, XII
b. V, VII, VIII
a. IX, XI, XII
Lateral compartment
a. IX, XI, XII
b. V, VII, VIII
b. V, VII, VIII
African horse sickness
a. Culicoides imicola (biting midge)
a. Culicoides imicola (biting midge)
EIV
a. RNA
b. DNA
a. RNA
EHV
a. RNA
b. DNA
b. DNA
MH
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1
a. RYR1
PSSM
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1
b. GYS-1
GBED
a. RYR1
b. GYS-1
c. TRPM1
d. GBE1
d. GBE1
HYPP
a. RYR1
b. SCN4A
c. GYS-1
d. TRPM1
b. SCN4A
Excitatory neurotransmitters
a. glutamate, aspartate and acetylcholine
b. GABA, glycine, taurine, norepinephrine
a. glutamate, aspartate and acetylcholine
Inhibitory neurotransmitters
a. glutamate, aspartate and acetylcholine
b. GABA, glycine, taurine, norepinephrine
b. GABA, glycine, taurine, norepinephrine
Type 1 diabetes mellitus
a. non-insulin dependent (tissue sensitivity impaired)
b. insulin dependent (lack of insulin)
b. insulin dependent (lack of insulin)
Type 2 diabetes mellitus
a. non-insulin dependent (tissue sensitivity impaired)
b. insulin dependent (lack of insulin)
a. non-insulin dependent (tissue sensitivity impaired)
Congential agangliosis
a. RYR1
b. SCN4A
c. EDNRB
d. TRPM1
c. EDNRB
Zone 1
a. periportal
b. centrolubular
a. periportal
Zone 3
a. periportal
b. centrolubular
b. centrolubular > KLOPT DIT?
Highest p450 mixed function oxidase
a. Zone 1
b. Zone 2
c. Zone 3
c. Zone 3
Highest p450 mixed function oxidase
a. periportal
b. centrolubular
b. centrolubular > KLOPT DIT?
Insulin vs. lipoprotein lipase
a. stimulation
b. inhibition
a. stimulation
Glucocorticoids vs. lipoprotein lipase
a. stimulation
b. inhibition
b. inhibition
Growth hormone vs. lipoprotein lipase
a. stimulation
b. inhibition
b. inhibition
Azotemia vs. lipoprotein lipase
a. stimulation
b. inhibition
b. inhibition
Insulin vs. hormone sensitive lipase
a. stimulation
b. inhibition
b. inhibition
Glucocorticoids vs. hormone sensitive lipase
a. stimulation
b. inhibition
a. stimulation
Growth hormone vs. hormone sensitive lipase
a. stimulation
b. inhibition
a. stimulation
Azotemia vs. hormone sensitive lipase
a. stimulation
b. inhibition
a. stimulationI
Insulin vs. gluconeogenesis
a. stimulation
b. inhibition
b. inhibition
Glucocorticoids vs. gluconeogenesis
a. stimulation
b. inhibition
a. stimulation
Glucagon vs. gluconeogenesis
a. stimulation
b. inhibition
a. stimulation
Catecholamines vs. gluconeogenesis
a. stimulation
b. inhibition
a. stimulation
Insulin vs. glycogenolysis
a. stimulation
b. inhibition
b. inhibition
Glucocorticoids vs. glycogenolysis
a. stimulation
b. inhibition
a. stimulation
Glucagon vs. glycogenolysis
a. stimulation
b. inhibition
a. stimulation
Insulin vs. fatty acid synthesis in liver
a. stimulation
b. inhibition
a. stimulation
Phase 1
a. oxygenation
b. conjugation
a. oxygenation
Phase 1
a. hydroxylation
b. conjugation
a. hydroxylation
Phase 1
a. deamination
b. conjugation
a. deamination
Phase 1
a. reduction
b. conjugation
a. reduction
Phase 2
a. hydroxylation
b. conjugation
c. deamination
d. reduction
b. conjugation
Centrilobular zonal injury
a. zone 1
b. zone 2
c. zone 3
c. zone 3
Periacinar (paracentral)
a. zone 1
b. zone 2
c. zone 3
c. zone 3
Compensatory pause
a. APCs
b. VPCs
b. VPCs
Acinuar lobular injury
a. zone 1
b. zone 2
c. zone 3
a. zone 1
Periportal injury
a. zone 1
b. zone 2
c. zone 3
a. zone 1
Conjugated <25%
a. hepatocellular disease
b. cholestasis
a. hepatocellular disease
Vitamine K dependent factors
a. III, IV, VIII, protein C
b. II, IV, XI, XII, protein C
c. IV, VI, IX, XI, protein C
d. II, VII, IX, X protein C
d. II, VII, IX, X and protein C
Volume overload receiving chamber VSD
a. LA and LV
b. RA and RV
a. LA and LV
Conjugated >30%
a. hepatocellular disease
b. cholestasis
b. cholestasis
Which valve has 2 cups?
a. tricuspid
b. mitral
c. pulomary
d. aorta
b. mitral
Volume overload receiving chamber PDA
a. LA and LV
b. RA and RV
a. LA and LV
Eccentric hypertrophy
a. endurance-trained
b. resistance trainend
a. endurance-trained
Concentric hypertrophy
a. endurance-trained
b. resistance trainend
b. resistance trainend
Volume overload receiving chamber ASD
a. LA and LV
b. RA and RV
b. RA and RV
S1
a. atrioventricular valve closure
b. semilunar valve closure
c. rapid ventricular filling
d. atrial contraction
a. atrioventricular valve closure
S2
a. rapid ventricular filling
b. atrial contraction
c. semilunar valve closure
d. atrioventricular valve closure
b. semilunar valve closure
S4
a. atrioventricular valve closure
b. semilunar valve closure
c. rapid ventricular filling
d. atrial contraction
d. atrial contraction
S3
a. rapid ventricular filling
b. semilunar valve closure
c. atrioventricular valve closure
d. atrial contraction
a. rapid ventricular filling
Non-compensatory pause
a. APCs
b. VPCs
a. APCs
PT
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen
aPTT
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
b. V, VII, X, prothrombin, fibrinogen
a. V, VIII, IX, X, XI, XII, prothrombin, fibrinogen
A1 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
a. no cutaenous involvement
A2 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
b. no cutaenous involvement but locally invasive
B1 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
c. overlying skin cannot be moved over nodule, no deep tissue invasion
B2 nodular sarcoid
a. no cutaenous involvement
b. no cutaenous involvement but locally invasive
c. overlying skin cannot be moved over nodule, no deep tissue invasion
d. overlying skin cannot be moved over nodule, attached to deeper tissues
d. overlying skin cannot be moved over nodule, attached to deeper tissues